Gastrointestinal dysfunction after liver transplantation
Conditions
Interventions
Zusanli by neostigmine (Group B):Conventional management protocol +ST36 acupoint injection with neostigmine
Zusanli by normal saline (Group C):Conventional management protocol +ST36 acupoint injection with normal saline
Conventional treatment (Group A):Conventional management protocol 1) Gastrointestinal decompression: 2) Intestinal stimulation therapy
3) Prokinetic drug therapy: 4) Intestinal microbiota regulating agents
Sponsors
The Fifth Clinical School of Henan University of Traditional Chinese Medicine (Zhengzhou People's Hospital)
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) liver transplantation surgery whether orthotopic liver transplantation or split liver transplantation; 2) no bowel sounds on auscultation and 3) symptomatic bloating and distention.
Exclusion criteria
Exclusion criteria: 1) local infection at injection site; 2) history of intestinal obstruction and constipation; 3) signs of peritoneal irritation (abdominal tension and tenderness or rebound tenderness; 4) history of intractable constipation; 5) history of coronary artery disease epilepsy ventricular tachycardia asthma; and 6) Mental disorders which might interfere with their participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recovery rate of gastrointestinal motility; | — |
Secondary
| Measure | Time frame |
|---|---|
| Time to first defecation;Time to first flatus; | — |
Countries
China
Contacts
Public ContactWanghongyu
The Fifth Clinical School of Henan University of Traditional Chinese Medicine (Zhengzhou People's Hospital)
Outcome results
None listed